Showing results (1-10 of 101) with videos related to
Sort By:
Pageof 11
Medicinal Research Reviews|June 2, 2004
Steroid sulfatase inhibitorsPeter Nussbaumer, Andreas BillichCurrent Medicinal Chemistry. Anti-Cancer Agents|September 24, 2005
Steroid sulfatase inhibitors: their potential in the therapy of breast cancerPeter Nussbaumer, Andreas BillichBioorganic & Medicinal Chemistry Letters|July 20, 2002
4,4'-Benzophenone-O,O'-disulfamate: a potent inhibitor of steroid sulfatasePeter Nussbaumer, Melitta Bilban, Andreas BillichJournal of Medicinal Chemistry|September 6, 2002
2-Substituted 4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatasePeter Nussbaumer, Philipp Lehr, Andreas BillichJournal of Medicinal Chemistry|October 31, 2003
Estrogenic potential of 2-alkyl-4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatasePeter Nussbaumer, Anthony P Winiski, Andreas BillichJournal of Medicinal Chemistry|August 6, 2004
2-(1-adamantyl)-4-(thio)chromenone-6-carboxylic acids: potent reversible inhibitors of human steroid sulfataseAmarylla Horvath, Peter Nussbaumer, Barbara Wolff, et al.Bioorganic & Medicinal Chemistry Letters|February 3, 2005
N-Acyl arylsulfonamides as novel, reversible inhibitors of human steroid sulfatasePhilipp Lehr, Andreas Billich, Barbara Wolff, et al.Bioorganic & Medicinal Chemistry Letters|October 14, 2003
Nortropinyl-arylsulfonylureas as novel, reversible inhibitors of human steroid sulfatasePeter Nussbaumer, Dieter Geyl, Amarylla Horvath, et al.Bioorganic & Medicinal Chemistry Letters|March 10, 2004
Fluorescence-labeled sphingosines as substrates of sphingosine kinases 1 and 2Peter Ettmayer, Andreas Billich, Thomas Baumruker, et al.The Journal of Organic Chemistry|January 26, 2007
Synthesis of borondipyrromethene (BODIPY)-labeled sphingosine derivatives by cross-metathesis reactionCarsten Peters, Andreas Billich, Michael Ghobrial, et al.Pageof 11